Digipath
Home > Boards > US Listed > Biotechs >

Neurotrope Inc. (NTRP)

NTRP RSS Feed
Add NTRP Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives, runncoach, grich1, Cyosol
Search This Board: 
Last Post: 1/21/2019 11:09:21 PM - Followers: 73 - Board type: Free - Posts Today: 0


 

Description:
Neurotrope Bioscience is a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders.
For more information, visit: http://www.neurotrope.com/

Market Information (as of September 30, 2018):
Symbol: NTRP
Stock Price: $8.81

Market Cap: $69,684,395
Outstanding Shares: 7,909,693
Public Float: 6,260,000
Warrants:
- 147,606 warrants exercisable at $0.32 ($47,233.92)
- 382,887 warrants exercisable at $6.40 ($2,450,476.80)
- 3,751,033 warrants exercisable at $12.80 ($48,013,222.40)
- 819,914 warrants exercisable at $32.00 ($26,237,248.00)
- $76,748,181.12 to be raised in total
Options Outstanding: 1,423,961
Fully Diluted Shares (Outstanding Shares + Warrants + Options Outstanding): 14,435,094
Fully Diluted Market Cap: $127,173,178

Links:
Presentations & press releases: http://www.neurotrope.com/ir/
Institutional ownership: https://fintel.io/so/us/ntrp
Relevant research articles: https://justpaste.it/4frnd
Patents by Daniel L. Alkon: https://patents.justia.com/inventor/daniel-l-alkon
Phase 2a and compassionate use patient results: https://content.iospress.com/articles/journal-of-alzheimers-disease/jad170161?resultNumber=0&totalResults=3&start=0&q=neurotrope&resultsPageSize=10&rows=10
Phase 2b results: https://www.prnewswire.com/news-releases/neurotropes-bryostatin-improves-cognition-in-patients-with-advanced-alzheimers-disease-based-on-further-analysis-of-phase-2-clinical-trial-data-300578025.html
Roth report: https://www.scribd.com/document/379434551/2018-03-08-NTRP-Roth-Init
Maxim report: https://www.scribd.com/document/379427337/NTRP-initiation
Memantine trial results: https://www.nejm.org/doi/full/10.1056/NEJMoa013128
Bryostatin vs. Memantine vs. Placebo comparison: https://i.imgur.com/579PX0L.jpg
Test comparison: https://i.imgur.com/s61opUd.jpg
Digipath
NTRP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NTRP News: Neurotrope to Participate in the Sachs Associates 2nd Annual Neuroscience Innovation Forum 01/03/2019 08:30:00 AM
NTRP News: Current Report Filing (8-k) 12/31/2018 04:32:01 PM
NTRP News: Statement of Ownership (sc 13g) 12/28/2018 01:59:14 PM
NTRP News: Statement of Changes in Beneficial Ownership (4) 12/17/2018 05:04:02 PM
NTRP News: Initial Statement of Beneficial Ownership (3) 12/17/2018 05:03:36 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#7563  Sticky Note Alkon interview. Bumped to the top so runncoach 12/17/18 09:06:30 AM
#710  Sticky Note Why I will be watching but not investing XenaLives 02/14/17 10:51:33 AM
#7859   Runn, if you were invested in both NTRP HANUMAN 01/21/19 11:09:21 PM
#7858   Finally got a chance to skim through last runncoach 01/21/19 04:07:55 PM
#7857   I think it's going to take nearly identical Antti 01/18/19 11:43:07 AM
#7856   They won't have to rush it. They'll runncoach 01/18/19 10:44:54 AM
#7855   Last patient finishes, then they have to review Biostudent 01/18/19 10:39:32 AM
#7854   FDA site says by end of July. runncoach 01/18/19 08:25:10 AM
#7853   Timing of release of trial results? Biostudent 01/18/19 08:11:05 AM
#7852   Watched the Glen Campbell movie last night "I'll runncoach 01/18/19 07:55:49 AM
#7851   Higher highs and higher lows so far in runncoach 01/17/19 02:23:29 PM
#7850   Patience is key. Time is on our side. Antti 01/16/19 01:17:48 PM
#7849   I wouldn't worry too much about what some Cyosol 01/16/19 12:36:31 PM
#7848   Yeah I'm not just talking about the markets runncoach 01/16/19 12:27:08 PM
#7847   I wouldn't worry too much about the market. Cyosol 01/16/19 12:19:46 PM
#7846   The guy can only see our drug through runncoach 01/16/19 11:30:44 AM
#7845   There's a reason for why this guy writes Cyosol 01/16/19 11:19:19 AM
#7844   Even though ongoing phase 2b is naturally where Antti 01/15/19 04:27:00 PM
#7843   Placebos are real regardless of the treatment or runncoach 01/15/19 03:43:16 PM
#7842   Exactly. There are always variability between patients and Antti 01/15/19 03:21:13 PM
#7841   For sure, and my bet is that it Whatsupp 01/14/19 02:27:31 PM
#7840   We've been warning people about placebo effect for runncoach 01/14/19 01:50:56 PM
#7839   He is also not up to date on Whatsupp 01/14/19 01:38:08 PM
#7838   One of the thing Lane never addresses is runncoach 01/14/19 01:28:25 PM
#7837   Absolutely. Thats why you run placebo controlled trials runncoach 01/14/19 12:26:12 PM
#7836   Lol and some claim no placebo effect in runncoach 01/14/19 12:21:41 PM
#7835   I would sum up my response to his InTheTrenches 01/14/19 12:17:24 PM
#7834   re. "everything hinges on this trial" FooBarAndGrill 01/14/19 12:07:22 PM
#7833   SA article out today with neutral/mildly negative bias Jerrymac1 01/14/19 11:58:17 AM
#7832   If your thinking of trial results and they’re Whoopddew 01/14/19 11:32:41 AM
#7831   Yeah now that the financing out of the runncoach 01/14/19 10:30:41 AM
#7830   Recognition. Biostudent 01/14/19 10:12:47 AM
#7829   Will be interesting to see how we close runncoach 01/11/19 12:28:40 PM
#7828   Ha ha. Yeah they must be in a runncoach 01/11/19 12:03:58 PM
#7827   That buyout rumor must be true if this Whoopddew 01/11/19 11:44:26 AM
#7826   Neurodiagnostics patent application updated last week. runncoach 01/09/19 08:51:47 PM
#7825   Your posts are very much appreciated. I'm just Cyosol 01/09/19 05:47:53 PM
#7824   I would hope that people that are familiar Whatsupp 01/09/19 10:37:02 AM
#7823   You're probably right that we won't get data InTheTrenches 01/09/19 09:45:02 AM
#7822   Sammie I think your first paragraph could be runncoach 01/09/19 09:16:48 AM
#7821   Looking for prudent and imprudent ways to management SammieGo 01/09/19 08:53:22 AM
#7820   Just posting what I find. Just like all runncoach 01/09/19 08:43:55 AM
#7819   Nice words, but it's clearly biased considering that Cyosol 01/09/19 08:35:39 AM
#7818   https://www.sickeconomics.com/2019/01/07/how-to-invest-10000-dollars-2019/ HO runncoach 01/09/19 07:49:00 AM
#7817   True. I can't imagine that that's going to runncoach 01/08/19 09:35:12 PM
#7816   Seems like a good analogy. InTheTrenches 01/08/19 09:32:27 PM
#7815   Yeah I posted a couple weeks back that runncoach 01/08/19 06:41:06 PM
#7814   Interesting NY Times review of the book "THE InTheTrenches 01/08/19 04:37:03 PM
#7813   Agreed and personally my last add was 3.46 Whoopddew 01/07/19 05:50:01 PM
#7812   A lot of shares traded below 3.60. runncoach 01/07/19 04:54:41 PM
#7811   Plenty of sellers remain in the new year Jerrymac1 01/07/19 04:51:45 PM
#7810   Yeah so far "january effect" has gone as runncoach 01/07/19 03:53:25 PM
PostSubject